Association between human-Pneumocystis infection and small-cell lung carcinoma

European Journal of Clinical Investigation

Volumn 34, Issue 3, 2004, Pages 229-235

  De La Horra, C ^a   Varela, J M ^a   Fernandez Alonso J ^a   Medrano, F J ^a   Respaldiza, N ^a   Montes Cano, M A ^a   Calderon E J ^a,b  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b Virgen del Rocio University Hospital ^*  (Spain)

Author keywords

Pathology; Pneumocystis; Small cell lung carcinoma

Indexed keywords

DIHYDROPTEROATE SYNTHASE; MITOCHONDRIAL DNA; RIBOSOME RNA;

ADULT; AGED; ARTICLE; CHRONIC INFLAMMATION; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; FEMALE; GENE LOCUS; HUMAN; HUMAN TISSUE; LUNG ALVEOLUS CELL; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MALE; PNEUMOCYSTOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; DNA, BACTERIAL; FEMALE; GENES, BACTERIAL; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PNEUMOCYSTIS JIROVECI; PNEUMONIA, PNEUMOCYSTIS;

EID: 1642523842     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2004.01317.x     Document Type: Article

References (31)

1. Newcomb PA, Carbone PP. The health consequences of smoking: cancer. Med Clin N Am 1992;76:305-31. [Review].
2. Junker K, Wiethege T, Müller KM. Pathology of small-cell lung cancer. J Cancer Res Clin Oncol 2000;126:361-8. [Review].
3. Díez Herranz A. Enfermedad pulmonar obstructiva crónica y cancer de pulmón: implicaciones prácticas. Arch Bronconeumol 2001;37:240-7. [Review].
4. Kuper H, Adami HO, Trichopoulos D. Infections as a major preventable cause of human cancer. J Intern Med 2000;248:171-83. [Review].
5. Pisani P, Parkin DM, Muñoz N, Ferlay J. Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Prev 1997;6:387-400. [Review].
6. Butel JS. Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease. Carcinogenesis 2000;21:405-26. [Review].
7. Persing DH, Prendergast FG. Infection, immunity, and cancer. Arch Pathol Lab Med 1999;123:1015-22. [Review].
8. Stringer JR, Beard CB, Miller RF, Wakefield AE. A new name (Pneumocystis jiroveci) for Pneumocystis from humans. Emerg Infect Dis 2002;8:891-6.
9. Calderón-Sandubete EJ, Varela-Aguilar JM, Medrano-Ortega FJ, Nieto-Guerrero V, Respaldiza-Salas N, de la Horra-Padilla C et al. Historial perspective on Pneumocystis carinii infection. Protist 2002;153:303-10. [Review].
10. Fossieck BE, Spagnolo SV. Pneumocystis carinii pneumonitis in patients with lung cancer. Chest 1980;78:721-2.
11. Cano S, Capote F, Pereira A, Calderón E, Castillo J. Pneumocystis carinii pneumonia in patients without predisposing illnesses. Acute episode and follow-up of five cases. Chest 1993;104:376-81.
12. Calderón EJ, Regordan C, Medrano FJ, Ollero M, Varela JM. Pneumocystis carinii infection in patients with chronic bronchial disease. Lancet 1996;347:977.
13. Armbruster C, Hassl A, Kriwanek S. Pneumocystis carinii colonization in the absence of immunosuppression. Scand J Infect Dis 1997;29:591-3.
14. Probost M, Ries H, Schmidt-Wieland T, Serr A. Detection of Pneumocystis carinii DNA in patients with chronic lung diseases. Eur J Clin Microbiol Infec Dis 2000;19:644-5.
15. Matusiewicz SP, Fergusson RF, Greening AP, Crompton GK, Burns SM. Pneumocystis carinii in bronchoalveolar lavage fluid and bronchial washing. Br Med J 1994;308:1206-7.
16. Prevost MC, Escamilla R, Aliouat EM, Cere N, Coudert P, Dei-Cas E. Pneumocystosis pathophysiology. FEMS Immunol Med Microbiol 1998;28:123-8. [Review].
17. Walzer PD. Pneumocystis carinii: recent advances in basic biology and their clinical application. AIDS 1993;7:1293-305. [Review].
18. Wakefield AE, Guiver L, Miller RF, Hopkin JM. DNA amplification on induced sputum samples for diagnosis of Pneumocystis carinii pneumonia. Lancet 1991;337:1378-9.
19. Helweg-Larsen J, Eugen-Olsen J, Lundgren B. Rapid detection of Dihydropteroate polymorphism in AIDS-related Pneumocystis carinii pneumonia by restriction fragment length polymorphism. Scand J Infect Dis 2000;32:481-3.
20. Leibovitz E, Pollack H, Moore T, Papellas J, Gallo L, Krasinski K et al. Comparison of PCR and standard cytological staining for detection of Pneumocystis carinii from respiratory specimens from patients with or at high risk for infection by Human Immunodeficiency Virus. J Clin Microbiol 1995;33:3004-7.
21. Kiessling R, Wasserman K, Horiguchi S, Kono K, Sjoberg J, Pisa P et al. Tumor-induced immune dysfunction. Cancer Immunol Immunother 1999;48:353-62. [Review].
22. Skerrett SJ. Host defenses against respiratory infection. Med Clin N Am 1994;78:941-66. [Review].
23. Klotz M, Blaes F, Funke D, Kalweit G, Schimrigk K, Huwer H. Shift in the IgG subclass distribution in patients with lung cancer. Lung Cancer 1999;24:25-30.
24. Domagala-Kulawik J, Hoser G, Droszcz P, Kawiak J, Droszcz W, Chazan R. T-cell subtypes in bronchoalveolar lavage fluid and in peripheral blood from patients with primary lung cancer. Diagn Cytopathol 2001;25:208-13.
25. Vázquez-Oliva R, Capote-Gil F, Verano-Rodríguez A, Ortega-Ruiz F, Rey-Pérez J, Castillo-Gómez J. Infección pulmonar en pacientes con cancer de pulmón. Med Clin 1993;101:488-91.
26. Remiszewski P, Slodkowska J, Wiatr E, Zych J, Radomski P, Rowinska-Zakrzewska E. Fatal infection in patients treated for small cell lung cancer in the Institute of Tuberculosis and Chest Diseases in the years 1980-94. Lung Cancer 2001;31:101-10.
27. Miller RF, Ambrose HE, Wakefield AE. Pneumocystis carinii f. sp. Hominis DNA in immunocompetent health care works in contact with patients with P. carinii pneumonia. J Clin Microbiol 2001;39:3877-82.
28. Benfield TL, Lundgren B, Shelhamer JH, Lundgren JD. Pneumocystis carinii major surface glycoprotein induces interleukin-8 and monocyte chemoattractant protein-I release from a human alveolar epithelial cell line. Eur J Clin Invest 1999;29:717-22.
29. Gentile JM, Gentile GJ. Implications for the involvement of the immune system in parasite-associated cancers. Mutat Res 1994;305:315-20. [Review].
30. Ohshima H, Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res 1994;305:253-64. [Review].
31. Cohen SM, Purtilo DT, Ellwein LB. Ideas in pathology. Pivotal role of increased cell proliferation in human carcinogenesis. Mod Pathol 1991;4:371-82. [Review].